Drug pipeline selected content

At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.

Expert primary care physicians discuss a study on the use of the KidneyIntelX test in patients with diabetic kidney disease (DKD). They discuss the practical and clinical implications of the risk assessment capabilities of the test to improve screening and health outcomes for patients at risk for progressive kidney failure related to DKD.

New study found that patients living in urban areas were more likely to meet all aspects of key metrics of diabetes care.

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

Findings highlight the need to develop strategies to improve weight management in primary care, according to study authors.

Bayer's investigational FXIa inhibitor is currently being studied in a large-scale phase 3 development program expected to enroll more than 27 000 participants.